Click for best price
Nuclear Radiopharmaceutical Market Size, Share 2024
The global Nuclear Radiopharmaceutical market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Diagnostic Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Nuclear Radiopharmaceutical include Nihon Medi-Physics Co.,Ltd., Curium Pharma, Cardinal Health, Bayer Global, GE Healthcare, Mallinckrodt Pharmaceuticals, Bracco Group, Advanced Molecular-imaging Solution and China Isotope & Radiation, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Nuclear Radiopharmaceuticals consist primarily of a radioactive isotope that is incorporated into a drug to assess the disease state in the body. The drug is used to deliver the radioactive isotope to an organ, tissue or specific cell in the body.
This report aims to provide a comprehensive presentation of the global market for Nuclear Radiopharmaceutical, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Radiopharmaceutical. This report contains market size and forecasts of Nuclear Radiopharmaceutical in global, including the following market information:
Global Nuclear Radiopharmaceutical Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Nuclear Radiopharmaceutical Market Sales, 2019-2024, 2025-2030, (Units)
Global top five Nuclear Radiopharmaceutical companies in 2023 (%)
We surveyed the Nuclear Radiopharmaceutical manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nuclear Radiopharmaceutical Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (Units)
Global Nuclear Radiopharmaceutical Market Segment Percentages, by Type, 2023 (%)
Diagnostic
Therapeutic
Global Nuclear Radiopharmaceutical Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (Units)
Global Nuclear Radiopharmaceutical Market Segment Percentages, by Application, 2023 (%)
Oncology
Thyroid
Cardiology
Others
Global Nuclear Radiopharmaceutical Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (Units)
Global Nuclear Radiopharmaceutical Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nuclear Radiopharmaceutical revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Nuclear Radiopharmaceutical revenues share in global market, 2023 (%)
Key companies Nuclear Radiopharmaceutical sales in global market, 2019-2024 (Estimated), (Units)
Key companies Nuclear Radiopharmaceutical sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Nihon Medi-Physics Co.,Ltd.
Curium Pharma
Cardinal Health
Bayer Global
GE Healthcare
Mallinckrodt Pharmaceuticals
Bracco Group
Advanced Molecular-imaging Solution
China Isotope & Radiation
Ciaeriar
Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nuclear Radiopharmaceutical, market overview.
Chapter 2: Global Nuclear Radiopharmaceutical market size in revenue and volume.
Chapter 3: Detailed analysis of Nuclear Radiopharmaceutical manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nuclear Radiopharmaceutical in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Nuclear Radiopharmaceutical capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Nuclear Radiopharmaceutical Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
79 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Nuclear Radiopharmaceutical Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nuclear Radiopharmaceutical Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nuclear Radiopharmaceutical Overall Market Size
2.1 Global Nuclear Radiopharmaceutical Market Size: 2023 VS 2030
2.2 Global Nuclear Radiopharmaceutical Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Nuclear Radiopharmaceutical Sales: 2019-2030
3 Company Landscape
3.1 Top Nuclear Radiopharmaceutical Players in Global Market
3.2 Top Global Nuclear Radiopharmaceutical Companies Ranked by Revenue
3.3 Global Nuclear Radiopharmaceutical Revenue by Companies
3.4 Global Nuclear Radiopharmaceutical Sales by Companies
3.5 Global Nuclear Radiopharmaceutical Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Nuclear Radiopharmaceutical Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Nuclear Radiopharmaceutical Product Type
3.8 Tier 1, Tier 2 and Tier 3 Nuclear Radiopharmaceutical Players in Global Market
3.8.1 List of Global Tier 1 Nuclear Radiopharmaceutical Companies
3.8.2 List of Global Tier 2 and Tier 3 Nuclear Radiopharmaceutical Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Nuclear Radiopharmaceutical Market Size Markets, 2023 & 2030
4.1.2 Diagnostic
4.1.3 Therapeutic
4.2 By Type - Global Nuclear Radiopharmaceutical Revenue & Forecasts
4.2.1 By Type - Global Nuclear Radiopharmaceutical Revenue, 2019-2024
4.2.2 By Type - Global Nuclear Radiopharmaceutical Revenue, 2025-2030
4.2.3 By Type - Global Nuclear Radiopharmaceutical Revenue Market Share, 2019-2030
4.3 By Type - Global Nuclear Radiopharmaceutical Sales & Forecasts
4.3.1 By Type - Global Nuclear Radiopharmaceutical Sales, 2019-2024
4.3.2 By Type - Global Nuclear Radiopharmaceutical Sales, 2025-2030
4.3.3 By Type - Global Nuclear Radiopharmaceutical Sales Market Share, 2019-2030
4.4 By Type - Global Nuclear Radiopharmaceutical Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Nuclear Radiopharmaceutical Market Size, 2023 & 2030
5.1.2 Oncology
5.1.3 Thyroid
5.1.4 Cardiology
5.1.5 Others
5.2 By Application - Global Nuclear Radiopharmaceutical Revenue & Forecasts
5.2.1 By Application - Global Nuclear Radiopharmaceutical Revenue, 2019-2024
5.2.2 By Application - Global Nuclear Radiopharmaceutical Revenue, 2025-2030
5.2.3 By Application - Global Nuclear Radiopharmaceutical Revenue Market Share, 2019-2030
5.3 By Application - Global Nuclear Radiopharmaceutical Sales & Forecasts
5.3.1 By Application - Global Nuclear Radiopharmaceutical Sales, 2019-2024
5.3.2 By Application - Global Nuclear Radiopharmaceutical Sales, 2025-2030
5.3.3 By Application - Global Nuclear Radiopharmaceutical Sales Market Share, 2019-2030
5.4 By Application - Global Nuclear Radiopharmaceutical Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Nuclear Radiopharmaceutical Market Size, 2023 & 2030
6.2 By Region - Global Nuclear Radiopharmaceutical Revenue & Forecasts
6.2.1 By Region - Global Nuclear Radiopharmaceutical Revenue, 2019-2024
6.2.2 By Region - Global Nuclear Radiopharmaceutical Revenue, 2025-2030
6.2.3 By Region - Global Nuclear Radiopharmaceutical Revenue Market Share, 2019-2030
6.3 By Region - Global Nuclear Radiopharmaceutical Sales & Forecasts
6.3.1 By Region - Global Nuclear Radiopharmaceutical Sales, 2019-2024
6.3.2 By Region - Global Nuclear Radiopharmaceutical Sales, 2025-2030
6.3.3 By Region - Global Nuclear Radiopharmaceutical Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Nuclear Radiopharmaceutical Revenue, 2019-2030
6.4.2 By Country - North America Nuclear Radiopharmaceutical Sales, 2019-2030
6.4.3 US Nuclear Radiopharmaceutical Market Size, 2019-2030
6.4.4 Canada Nuclear Radiopharmaceutical Market Size, 2019-2030
6.4.5 Mexico Nuclear Radiopharmaceutical Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Nuclear Radiopharmaceutical Revenue, 2019-2030
6.5.2 By Country - Europe Nuclear Radiopharmaceutical Sales, 2019-2030
6.5.3 Germany Nuclear Radiopharmaceutical Market Size, 2019-2030
6.5.4 France Nuclear Radiopharmaceutical Market Size, 2019-2030
6.5.5 U.K. Nuclear Radiopharmaceutical Market Size, 2019-2030
6.5.6 Italy Nuclear Radiopharmaceutical Market Size, 2019-2030
6.5.7 Russia Nuclear Radiopharmaceutical Market Size, 2019-2030
6.5.8 Nordic Countries Nuclear Radiopharmaceutical Market Size, 2019-2030
6.5.9 Benelux Nuclear Radiopharmaceutical Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Nuclear Radiopharmaceutical Revenue, 2019-2030
6.6.2 By Region - Asia Nuclear Radiopharmaceutical Sales, 2019-2030
6.6.3 China Nuclear Radiopharmaceutical Market Size, 2019-2030
6.6.4 Japan Nuclear Radiopharmaceutical Market Size, 2019-2030
6.6.5 South Korea Nuclear Radiopharmaceutical Market Size, 2019-2030
6.6.6 Southeast Asia Nuclear Radiopharmaceutical Market Size, 2019-2030
6.6.7 India Nuclear Radiopharmaceutical Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Nuclear Radiopharmaceutical Revenue, 2019-2030
6.7.2 By Country - South America Nuclear Radiopharmaceutical Sales, 2019-2030
6.7.3 Brazil Nuclear Radiopharmaceutical Market Size, 2019-2030
6.7.4 Argentina Nuclear Radiopharmaceutical Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Nuclear Radiopharmaceutical Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Nuclear Radiopharmaceutical Sales, 2019-2030
6.8.3 Turkey Nuclear Radiopharmaceutical Market Size, 2019-2030
6.8.4 Israel Nuclear Radiopharmaceutical Market Size, 2019-2030
6.8.5 Saudi Arabia Nuclear Radiopharmaceutical Market Size, 2019-2030
6.8.6 UAE Nuclear Radiopharmaceutical Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Nihon Medi-Physics Co.,Ltd.
7.1.1 Nihon Medi-Physics Co.,Ltd. Company Summary
7.1.2 Nihon Medi-Physics Co.,Ltd. Business Overview
7.1.3 Nihon Medi-Physics Co.,Ltd. Nuclear Radiopharmaceutical Major Product Offerings
7.1.4 Nihon Medi-Physics Co.,Ltd. Nuclear Radiopharmaceutical Sales and Revenue in Global (2019-2024)
7.1.5 Nihon Medi-Physics Co.,Ltd. Key News & Latest Developments
7.2 Curium Pharma
7.2.1 Curium Pharma Company Summary
7.2.2 Curium Pharma Business Overview
7.2.3 Curium Pharma Nuclear Radiopharmaceutical Major Product Offerings
7.2.4 Curium Pharma Nuclear Radiopharmaceutical Sales and Revenue in Global (2019-2024)
7.2.5 Curium Pharma Key News & Latest Developments
7.3 Cardinal Health
7.3.1 Cardinal Health Company Summary
7.3.2 Cardinal Health Business Overview
7.3.3 Cardinal Health Nuclear Radiopharmaceutical Major Product Offerings
7.3.4 Cardinal Health Nuclear Radiopharmaceutical Sales and Revenue in Global (2019-2024)
7.3.5 Cardinal Health Key News & Latest Developments
7.4 Bayer Global
7.4.1 Bayer Global Company Summary
7.4.2 Bayer Global Business Overview
7.4.3 Bayer Global Nuclear Radiopharmaceutical Major Product Offerings
7.4.4 Bayer Global Nuclear Radiopharmaceutical Sales and Revenue in Global (2019-2024)
7.4.5 Bayer Global Key News & Latest Developments
7.5 GE Healthcare
7.5.1 GE Healthcare Company Summary
7.5.2 GE Healthcare Business Overview
7.5.3 GE Healthcare Nuclear Radiopharmaceutical Major Product Offerings
7.5.4 GE Healthcare Nuclear Radiopharmaceutical Sales and Revenue in Global (2019-2024)
7.5.5 GE Healthcare Key News & Latest Developments
7.6 Mallinckrodt Pharmaceuticals
7.6.1 Mallinckrodt Pharmaceuticals Company Summary
7.6.2 Mallinckrodt Pharmaceuticals Business Overview
7.6.3 Mallinckrodt Pharmaceuticals Nuclear Radiopharmaceutical Major Product Offerings
7.6.4 Mallinckrodt Pharmaceuticals Nuclear Radiopharmaceutical Sales and Revenue in Global (2019-2024)
7.6.5 Mallinckrodt Pharmaceuticals Key News & Latest Developments
7.7 Bracco Group
7.7.1 Bracco Group Company Summary
7.7.2 Bracco Group Business Overview
7.7.3 Bracco Group Nuclear Radiopharmaceutical Major Product Offerings
7.7.4 Bracco Group Nuclear Radiopharmaceutical Sales and Revenue in Global (2019-2024)
7.7.5 Bracco Group Key News & Latest Developments
7.8 Advanced Molecular-imaging Solution
7.8.1 Advanced Molecular-imaging Solution Company Summary
7.8.2 Advanced Molecular-imaging Solution Business Overview
7.8.3 Advanced Molecular-imaging Solution Nuclear Radiopharmaceutical Major Product Offerings
7.8.4 Advanced Molecular-imaging Solution Nuclear Radiopharmaceutical Sales and Revenue in Global (2019-2024)
7.8.5 Advanced Molecular-imaging Solution Key News & Latest Developments
7.9 China Isotope & Radiation
7.9.1 China Isotope & Radiation Company Summary
7.9.2 China Isotope & Radiation Business Overview
7.9.3 China Isotope & Radiation Nuclear Radiopharmaceutical Major Product Offerings
7.9.4 China Isotope & Radiation Nuclear Radiopharmaceutical Sales and Revenue in Global (2019-2024)
7.9.5 China Isotope & Radiation Key News & Latest Developments
7.10 Ciaeriar
7.10.1 Ciaeriar Company Summary
7.10.2 Ciaeriar Business Overview
7.10.3 Ciaeriar Nuclear Radiopharmaceutical Major Product Offerings
7.10.4 Ciaeriar Nuclear Radiopharmaceutical Sales and Revenue in Global (2019-2024)
7.10.5 Ciaeriar Key News & Latest Developments
7.11 Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
7.11.1 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Company Summary
7.11.2 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiopharmaceutical Business Overview
7.11.3 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiopharmaceutical Major Product Offerings
7.11.4 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiopharmaceutical Sales and Revenue in Global (2019-2024)
7.11.5 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Key News & Latest Developments
8 Global Nuclear Radiopharmaceutical Production Capacity, Analysis
8.1 Global Nuclear Radiopharmaceutical Production Capacity, 2019-2030
8.2 Nuclear Radiopharmaceutical Production Capacity of Key Manufacturers in Global Market
8.3 Global Nuclear Radiopharmaceutical Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Nuclear Radiopharmaceutical Supply Chain Analysis
10.1 Nuclear Radiopharmaceutical Industry Value Chain
10.2 Nuclear Radiopharmaceutical Upstream Market
10.3 Nuclear Radiopharmaceutical Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Nuclear Radiopharmaceutical Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Nuclear Radiopharmaceutical in Global Market
Table 2. Top Nuclear Radiopharmaceutical Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Nuclear Radiopharmaceutical Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Nuclear Radiopharmaceutical Revenue Share by Companies, 2019-2024
Table 5. Global Nuclear Radiopharmaceutical Sales by Companies, (Units), 2019-2024
Table 6. Global Nuclear Radiopharmaceutical Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Nuclear Radiopharmaceutical Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Nuclear Radiopharmaceutical Product Type
Table 9. List of Global Tier 1 Nuclear Radiopharmaceutical Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nuclear Radiopharmaceutical Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Nuclear Radiopharmaceutical Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Nuclear Radiopharmaceutical Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Nuclear Radiopharmaceutical Sales (Units), 2019-2024
Table 15. By Type - Global Nuclear Radiopharmaceutical Sales (Units), 2025-2030
Table 16. By Application ? Global Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Nuclear Radiopharmaceutical Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Nuclear Radiopharmaceutical Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Nuclear Radiopharmaceutical Sales (Units), 2019-2024
Table 20. By Application - Global Nuclear Radiopharmaceutical Sales (Units), 2025-2030
Table 21. By Region ? Global Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Nuclear Radiopharmaceutical Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Nuclear Radiopharmaceutical Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Nuclear Radiopharmaceutical Sales (Units), 2019-2024
Table 25. By Region - Global Nuclear Radiopharmaceutical Sales (Units), 2025-2030
Table 26. By Country - North America Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Nuclear Radiopharmaceutical Sales, (Units), 2019-2024
Table 29. By Country - North America Nuclear Radiopharmaceutical Sales, (Units), 2025-2030
Table 30. By Country - Europe Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Nuclear Radiopharmaceutical Sales, (Units), 2019-2024
Table 33. By Country - Europe Nuclear Radiopharmaceutical Sales, (Units), 2025-2030
Table 34. By Region - Asia Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Nuclear Radiopharmaceutical Sales, (Units), 2019-2024
Table 37. By Region - Asia Nuclear Radiopharmaceutical Sales, (Units), 2025-2030
Table 38. By Country - South America Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Nuclear Radiopharmaceutical Sales, (Units), 2019-2024
Table 41. By Country - South America Nuclear Radiopharmaceutical Sales, (Units), 2025-2030
Table 42. By Country - Middle East & Africa Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Nuclear Radiopharmaceutical Sales, (Units), 2019-2024
Table 45. By Country - Middle East & Africa Nuclear Radiopharmaceutical Sales, (Units), 2025-2030
Table 46. Nihon Medi-Physics Co.,Ltd. Company Summary
Table 47. Nihon Medi-Physics Co.,Ltd. Nuclear Radiopharmaceutical Product Offerings
Table 48. Nihon Medi-Physics Co.,Ltd. Nuclear Radiopharmaceutical Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Nihon Medi-Physics Co.,Ltd. Key News & Latest Developments
Table 50. Curium Pharma Company Summary
Table 51. Curium Pharma Nuclear Radiopharmaceutical Product Offerings
Table 52. Curium Pharma Nuclear Radiopharmaceutical Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Curium Pharma Key News & Latest Developments
Table 54. Cardinal Health Company Summary
Table 55. Cardinal Health Nuclear Radiopharmaceutical Product Offerings
Table 56. Cardinal Health Nuclear Radiopharmaceutical Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Cardinal Health Key News & Latest Developments
Table 58. Bayer Global Company Summary
Table 59. Bayer Global Nuclear Radiopharmaceutical Product Offerings
Table 60. Bayer Global Nuclear Radiopharmaceutical Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Bayer Global Key News & Latest Developments
Table 62. GE Healthcare Company Summary
Table 63. GE Healthcare Nuclear Radiopharmaceutical Product Offerings
Table 64. GE Healthcare Nuclear Radiopharmaceutical Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. GE Healthcare Key News & Latest Developments
Table 66. Mallinckrodt Pharmaceuticals Company Summary
Table 67. Mallinckrodt Pharmaceuticals Nuclear Radiopharmaceutical Product Offerings
Table 68. Mallinckrodt Pharmaceuticals Nuclear Radiopharmaceutical Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Mallinckrodt Pharmaceuticals Key News & Latest Developments
Table 70. Bracco Group Company Summary
Table 71. Bracco Group Nuclear Radiopharmaceutical Product Offerings
Table 72. Bracco Group Nuclear Radiopharmaceutical Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Bracco Group Key News & Latest Developments
Table 74. Advanced Molecular-imaging Solution Company Summary
Table 75. Advanced Molecular-imaging Solution Nuclear Radiopharmaceutical Product Offerings
Table 76. Advanced Molecular-imaging Solution Nuclear Radiopharmaceutical Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Advanced Molecular-imaging Solution Key News & Latest Developments
Table 78. China Isotope & Radiation Company Summary
Table 79. China Isotope & Radiation Nuclear Radiopharmaceutical Product Offerings
Table 80. China Isotope & Radiation Nuclear Radiopharmaceutical Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. China Isotope & Radiation Key News & Latest Developments
Table 82. Ciaeriar Company Summary
Table 83. Ciaeriar Nuclear Radiopharmaceutical Product Offerings
Table 84. Ciaeriar Nuclear Radiopharmaceutical Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Ciaeriar Key News & Latest Developments
Table 86. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Company Summary
Table 87. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiopharmaceutical Product Offerings
Table 88. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiopharmaceutical Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Key News & Latest Developments
Table 90. Nuclear Radiopharmaceutical Production Capacity (Units) of Key Manufacturers in Global Market, 2022-2024 (Units)
Table 91. Global Nuclear Radiopharmaceutical Capacity Market Share of Key Manufacturers, 2022-2024
Table 92. Global Nuclear Radiopharmaceutical Production by Region, 2019-2024 (Units)
Table 93. Global Nuclear Radiopharmaceutical Production by Region, 2025-2030 (Units)
Table 94. Nuclear Radiopharmaceutical Market Opportunities & Trends in Global Market
Table 95. Nuclear Radiopharmaceutical Market Drivers in Global Market
Table 96. Nuclear Radiopharmaceutical Market Restraints in Global Market
Table 97. Nuclear Radiopharmaceutical Raw Materials
Table 98. Nuclear Radiopharmaceutical Raw Materials Suppliers in Global Market
Table 99. Typical Nuclear Radiopharmaceutical Downstream
Table 100. Nuclear Radiopharmaceutical Downstream Clients in Global Market
Table 101. Nuclear Radiopharmaceutical Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Nuclear Radiopharmaceutical Segment by Type in 2023
Figure 2. Nuclear Radiopharmaceutical Segment by Application in 2023
Figure 3. Global Nuclear Radiopharmaceutical Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Nuclear Radiopharmaceutical Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Nuclear Radiopharmaceutical Revenue, 2019-2030 (US$, Mn)
Figure 7. Nuclear Radiopharmaceutical Sales in Global Market: 2019-2030 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Nuclear Radiopharmaceutical Revenue in 2023
Figure 9. By Type - Global Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Nuclear Radiopharmaceutical Revenue Market Share, 2019-2030
Figure 11. By Type - Global Nuclear Radiopharmaceutical Sales Market Share, 2019-2030
Figure 12. By Type - Global Nuclear Radiopharmaceutical Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Nuclear Radiopharmaceutical Revenue Market Share, 2019-2030
Figure 15. By Application - Global Nuclear Radiopharmaceutical Sales Market Share, 2019-2030
Figure 16. By Application - Global Nuclear Radiopharmaceutical Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Nuclear Radiopharmaceutical Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Nuclear Radiopharmaceutical Revenue Market Share, 2019-2030
Figure 20. By Region - Global Nuclear Radiopharmaceutical Sales Market Share, 2019-2030
Figure 21. By Country - North America Nuclear Radiopharmaceutical Revenue Market Share, 2019-2030
Figure 22. By Country - North America Nuclear Radiopharmaceutical Sales Market Share, 2019-2030
Figure 23. US Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Nuclear Radiopharmaceutical Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Nuclear Radiopharmaceutical Sales Market Share, 2019-2030
Figure 28. Germany Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2019-2030
Figure 29. France Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Nuclear Radiopharmaceutical Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Nuclear Radiopharmaceutical Sales Market Share, 2019-2030
Figure 37. China Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2019-2030
Figure 41. India Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Nuclear Radiopharmaceutical Revenue Market Share, 2019-2030
Figure 43. By Country - South America Nuclear Radiopharmaceutical Sales Market Share, 2019-2030
Figure 44. Brazil Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Nuclear Radiopharmaceutical Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Nuclear Radiopharmaceutical Sales Market Share, 2019-2030
Figure 48. Turkey Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Nuclear Radiopharmaceutical Revenue, (US$, Mn), 2019-2030
Figure 52. Global Nuclear Radiopharmaceutical Production Capacity (Units), 2019-2030
Figure 53. The Percentage of Production Nuclear Radiopharmaceutical by Region, 2023 VS 2030
Figure 54. Nuclear Radiopharmaceutical Industry Value Chain
Figure 55. Marketing Channels
